focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: RBC Upgrades IMI And Downgrades Rotork

Tue, 14th Jul 2020 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

CREDIT SUISSE RAISES HALMA PRICE TARGET TO 2530 (2030) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES JOHNSON MATTHEY TARGET TO 3500 (3400) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES CRODA INTERNATIONAL TARGET TO 5100 (4500) PENCE - 'MARKET-PERFORM'

----------

BARCLAYS RAISES FLUTTER PRICE TARGET TO 10500 (10000) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES SMITHS PRICE TARGET TO 1530 (1300) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS STANDARD CHARTERED PRICE TARGET TO 690 (730) PENCE - 'BUY'

----------

GOLDMAN CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 195 (215) PENCE - 'BUY'

----------

GOLDMAN CUTS LLOYDS BANKING PRICE TARGET TO 29 (32) PENCE - 'SELL'

----------

GOLDMAN CUTS BARCLAYS PRICE TARGET TO 135 (150) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS HSBC TO 'BUY' ('CONVICTION BUY LIST') - PRICE TARGET 565 (695) PENCE

----------

DEUTSCHE BANK CUTS BARCLAYS PRICE TARGET TO 135 (208) PENCE - 'BUY'

----------

DEUTSCHE BANK RESUMES STANDARD CHARTERED WITH 'HOLD' - TARGET 415 PENCE

----------

DEUTSCHE BANK RESUMES RBS WITH 'SELL' - TARGET 100 PENCE

----------

DEUTSCHE BANK REINITIATES LLOYDS BANKING WITH 'HOLD' - PRICE TARGET 34 PENCE

----------

DEUTSCHE BANK REINITIATES HSBC WITH 'SELL' - PRICE TARGET 335 PENCE

----------

JPMORGAN RAISES LEGAL & GENERAL TARGET TO 202 (200) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

DEUTSCHE BANK RAISES G4S TO 'BUY' ('HOLD') - TARGET 160 (140) PENCE

----------

DEUTSCHE BANK RESUMES VIRGIN MONEY WITH 'BUY' - TARGET 105 PENCE

----------

JPMORGAN CUTS JOHN WOOD PRICE TARGET TO 400 (590) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES AVON RUBBER PRICE TARGET TO 3510 (2435) PENCE - 'HOLD'

----------

BERENBERG CUTS PRIMARY HEALTH PROPERTIES TO 'HOLD' ('BUY') - TARGET 155 (150) PENCE

----------

BERENBERG CUTS CENTAMIN TO 'HOLD' ('BUY') - TARGET 200 (190) PENCE

----------

BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 200 (210) PENCE - 'OVERWEIGHT'

----------

RBC RAISES BODYCOTE PRICE TARGET TO 710 (650) PENCE - 'OUTPERFORM'

----------

RBC RAISES MORGAN ADVANCED TO SECTOR PERFORM ('UNDERPERFORM') - TARGET 275 (250) PENCE

----------

RBC CUTS ROTORK TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 275 (265) PENCE

----------

RBC RAISES IMI TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1140 (1000) PENCE

----------

GOLDMAN CUTS VIRGIN MONEY PRICE TARGET TO 95 (100) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HOCHSCHILD MINING TARGET TO 180 (170) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES SPIRENT PRICE TARGET TO 325 (290) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RESUMES MITIE GROUP WITH 'HOLD' - TARGET 43 PENCE

----------

BERENBERG RAISES CONNECT GROUP TO 'BUY' ('HOLD') - TARGET 27 (15) PENCE

----------

DEUTSCHE BANK CUTS FORTERRA PRICE TARGET TO 234 (340) PENCE - 'BUY'

----------

BERNSTEIN CUTS BOOHOO PRICE TARGET TO 350 (480) PENCE - 'OUTPERFORM'

----------

BERENBERG CUTS KENMARE RESOURCES PRICE TARGET TO 370 (380) PENCE - 'BUY'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 1300 (1500) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS HUNTING PRICE TARGET TO 210 (460) PENCE - 'NEUTRAL'

----------

RBC RAISES RESTAURANT GROUP TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 80 (70) PENCE

----------

GOLDMAN CUTS BANK OF IRELAND PRICE TARGET TO 1.75 (2) EUR - 'NEUTRAL'

----------

GOLDMAN CUTS AIB GROUP PRICE TARGET TO 1.80 (2.20) EUR - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
7 Nov 2016 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
30 Oct 2016 14:52

Sunday newspaper round-up: More 'Nissan' deals, Carney, RBS, HSBC, Capita

(ShareCast News) - Pharmaceuticals giants want the government to plug a £1bn-a-year funding gap that will be created when Britain leaves the EU, as part of a list of demands being drawn up by big business after last week's deal with Nissan. After the Japanese car maker said it would make two new mod

Read more
25 Oct 2016 08:50

Clinigen Group extends partnership with BTG

(ShareCast News) - AIM-listed pharmaceutical Clinigen Group's Idis Global Access division extended its four-year partnership with BTG, a healthcare company, to manage its critical care portfolio across the whole of Europe and new territories in Asia. The agreement now includes all of Europe and some

Read more
25 Oct 2016 06:37

Clinigen Group Extends Exclusive Supply Agreement With BTG

Read more
18 Oct 2016 08:36

Clinigen expands operations into Japan

(ShareCast News) - Clinigen Group, an AIM listed global pharmaceuticals and services company, has extended its geographical reach to Japan with the opening of a new office in Tokyo. Clinigen KK further expands the group's presence in Asia following the company's acquisition of Link healthcare in 201

Read more
18 Oct 2016 07:45

Clinigen Opens Tokyo Office To Take Foscavir Marketing Back In-House

Read more
5 Oct 2016 16:13

DIRECTOR DEALINGS SUMMARY: Clinigen Executive Slashes Shareholding

Read more
28 Sep 2016 09:43

WINNERS & LOSERS SUMMARY: UK Mail Jumps On Deutsche Post Cash Offer

Read more
22 Jul 2016 10:21

Clinigen Group issues 38k option shares

(ShareCast News) - Clinigen Group announced on Friday that it has made an application for the admission to trading on AIM of 38,308 ordinary shares of 0.1p each. The firm said the shares have been issued to satisfy the exercise of share options, and rank pari passu with the existing shares of the gr

Read more
20 Jul 2016 14:42

Clinigen revenue and profits see serious rise

(ShareCast News) - Global pharmaceutical and services company Clinigen Group posted a trading update for the year to 30 June on Wednesday, reporting an 87% improvement in revenue and a 90% increase in gross profit. The AIM-traded firm said the growth was driven primarily by acquisitions and organic

Read more
20 Jul 2016 09:47

WINNERS & LOSERS SUMMARY: Man Group Down As CEO Departs For PIMCO

Read more
20 Jul 2016 07:02

Clinigen Revenue And Profit Surge On Acquisitions, Organic Growth

Read more
13 Jul 2016 15:02

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
7 Jul 2016 15:27

Clinigen Group Issues 83,016 Shares In Option Exercise (ALLISS)

Read more
29 Jun 2016 12:20

Clinigen teams up with Horizon on RAVICTI

(ShareCast News) - Clinigen Group was celebrating on Wednesday, as its Idis Managed Access division and Nasdaq-traded Horizon Pharma initiated a Managed Access Programme in Europe for Horizon's RAVICTI oral liquid. The AIM-traded firm said RAVICTI received centralised marketing approval from the Eur

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.